GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000003 | Reproduction |
| Process | GO:0001541 | Ovarian follicle development |
| Process | GO:0001546 | Preantral ovarian follicle growth |
| Process | GO:0001655 | Urogenital system development |
| Process | GO:0001880 | Mullerian duct regression |
| Process | GO:0003006 | Developmental process involved in reproduction |
| Process | GO:0006355 | Regulation of transcription, DNA-templated |
| Process | GO:0006468 | Protein phosphorylation |
| Process | GO:0006793 | Phosphorus metabolic process |
| Process | GO:0006796 | Phosphate-containing compound metabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007166 | Cell surface receptor signaling pathway |
| Process | GO:0007167 | Enzyme-linked receptor protein signaling pathway |
| Process | GO:0007178 | Transmembrane receptor protein serine/threonine kinase signaling pathway |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0007276 | Gamete generation |
| Process | GO:0007281 | Germ cell development |
| Process | GO:0007292 | Female gamete generation |
| Process | GO:0007498 | Mesoderm development |
| Process | GO:0007506 | Gonadal mesoderm development |
| Process | GO:0007530 | Sex determination |
| Process | GO:0007548 | Sex differentiation |
| Process | GO:0007568 | Aging |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008406 | Gonad development |
| Process | GO:0008584 | Male gonad development |
| Process | GO:0008585 | Female gonad development |
| Process | GO:0009410 | Response to xenobiotic stimulus |
| Process | GO:0009653 | Anatomical structure morphogenesis |
| Process | GO:0009888 | Tissue development |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010556 | Regulation of macromolecule biosynthetic process |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010628 | Positive regulation of gene expression |
| Process | GO:0014070 | Response to organic cyclic compound |
| Process | GO:0016310 | Phosphorylation |
| Process | GO:0019219 | Regulation of nucleobase-containing compound metabolic process |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019538 | Protein metabolic process |
| Process | GO:0019953 | Sexual reproduction |
| Process | GO:0022412 | Cellular process involved in reproduction in multicellular organism |
| Process | GO:0022414 | Reproductive process |
| Process | GO:0022602 | Ovulation cycle process |
| Process | GO:0022605 | Mammalian oogenesis stage |
| Process | GO:0023052 | Signaling |
| Process | GO:0030154 | Cell differentiation |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031326 | Regulation of cellular biosynthetic process |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032504 | Multicellular organism reproduction |
| Process | GO:0033327 | Leydig cell differentiation |
| Process | GO:0036211 | Protein modification process |
| Process | GO:0040007 | Growth |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042698 | Ovulation cycle |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043412 | Macromolecule modification |
| Process | GO:0044093 | Positive regulation of molecular function |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0045137 | Development of primary sexual characteristics |
| Process | GO:0046545 | Development of primary female sexual characteristics |
| Process | GO:0046546 | Development of primary male sexual characteristics |
| Process | GO:0046660 | Female sex differentiation |
| Process | GO:0046661 | Male sex differentiation |
| Process | GO:0048162 | Multi-layer follicle stage |
| Process | GO:0048468 | Cell development |
| Process | GO:0048477 | Oogenesis |
| Process | GO:0048511 | Rhythmic process |
| Process | GO:0048513 | Animal organ development |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048589 | Developmental growth |
| Process | GO:0048608 | Reproductive structure development |
| Process | GO:0048609 | Multicellular organismal reproductive process |
| Process | GO:0048731 | System development |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0048869 | Cellular developmental process |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050793 | Regulation of developmental process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051090 | Regulation of DNA-binding transcription factor activity |
| Process | GO:0051091 | Positive regulation of DNA-binding transcription factor activity |
| Process | GO:0051092 | Positive regulation of NF-kappaB transcription factor activity |
| Process | GO:0051093 | Negative regulation of developmental process |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051252 | Regulation of RNA metabolic process |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0060033 | Anatomical structure regression |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060389 | Pathway-restricted SMAD protein phosphorylation |
| Process | GO:0060485 | Mesenchyme development |
| Process | GO:0061458 | Reproductive system development |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:1901564 | Organonitrogen compound metabolic process |
| Process | GO:1903506 | Regulation of nucleic acid-templated transcription |
| Process | GO:2000241 | Regulation of reproductive process |
| Process | GO:2000242 | Negative regulation of reproductive process |
| Process | GO:2000354 | Regulation of ovarian follicle development |
| Process | GO:2000355 | Negative regulation of ovarian follicle development |
| Process | GO:2001141 | Regulation of RNA biosynthetic process |
| Component | GO:0005576 | Extracellular region |
| Component | GO:0005615 | Extracellular space |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0110165 | Cellular anatomical entity |
| Function | GO:0005102 | Signaling receptor binding |
| Function | GO:0005114 | Type II transforming growth factor beta receptor binding |
| Function | GO:0005126 | Cytokine receptor binding |
| Function | GO:0005160 | Transforming growth factor beta receptor binding |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0008083 | Growth factor activity |
| Function | GO:0030545 | Signaling receptor regulator activity |
| Function | GO:0030546 | Signaling receptor activator activity |
| Function | GO:0048018 | Receptor ligand activity |
| Function | GO:0098772 | Molecular function regulator activity |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-162582 | Signal Transduction |
| RCTM | RNO-201451 | Signaling by BMP |
| RCTM | RNO-9006936 | Signaling by TGFB family members |
| KEGG | rno04024 | cAMP signaling pathway |
| KEGG | rno04060 | Cytokine-cytokine receptor interaction |
| KEGG | rno04350 | TGF-beta signaling pathway |
| KEGG | rno04390 | Hippo signaling pathway |
Expression profile of Amh in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 6.057577 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 6.1212087 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 5.8755436 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 6.0754876 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 5.5819125 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 5.756453 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 5.6843457 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 5.7624526 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 6.4828987 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 6.5001793 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 6.3664737 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 6.1101522 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 6.489179 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 6.3395305 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 6.421673 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 6.5293016 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 5.9662213 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 6.3985815 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 6.0217404 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 6.065221 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 6.1792116 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 6.12216 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 6.227225 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 6.2834783 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 3.829041156 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 3.697354816 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 3.74906198 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 3.761061349 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 3.967805506 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 3.792138403 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 3.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 4.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 3.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 3.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 7.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 4.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 4.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 10.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 2.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 2.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 2.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 6.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 5.624773 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 6.050597 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 5.84913 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 6.296613 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 5.737535 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 5.692324 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 0.3 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 0.36 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 0.434 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 0.33 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 0.479 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 4.642731232 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 5.736486913 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 3.971138352 |
| ID | GSE1616 |
| Title | Genomics of preconditioning |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM27484 | APC_a (anesthetic-preconditioning, 1st replicate) | 454.9 | |
| GSM27485 | APC_b (anesthetic-preconditioning, 2nd replicate) | 283.8 | |
| GSM27486 | APC_c (anesthetic-preconditioning, 3rd replicate) | 317.9 | |
| GSM27487 | APC_d (anesthetic-preconditioning, 4th replicate) | 424.5 | |
| GSM27488 | APC_e (anesthetic-preconditioning, 5th replicate) | 395.7 | |
| GSM27489 | APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) | 285.7 | |
| GSM27490 | APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) | 317.7 | |
| GSM27491 | APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) | 281.1 | |
| GSM27492 | APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) | 382.8 | |
| GSM27493 | APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) | 316.4 | |
| GSM27494 | CTL_a (control, 1st replicate) | 424.3 | |
| GSM27495 | CTL_b (control, 2nd replicate) | 339.9 | |
| GSM27496 | CTL_c (control, 3rd replicate) | 368.3 | |
| GSM27497 | CTL_d (control, 4th replicate) | 308.7 | |
| GSM27498 | CTL_e (control, 5th replicate) | 450.0 | |
| GSM27499 | IPC_a (ischemic preconditioning, 1st replicate) | 374.6 | |
| GSM27500 | IPC_b (ischemic preconditioning, 2nd replicate) | 339.7 | |
| GSM27501 | IPC_c (ischemic preconditioning, 3rd replicate) | 387.1 | |
| GSM27502 | IPC_d (ischemic preconditioning, 4th replicate) | 261.6 | |
| GSM27503 | IPC_e (ischemic preconditioning, 5th replicate) | 220.8 | |
| GSM27504 | IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) | 356.3 | |
| GSM27505 | IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) | 134.6 | |
| GSM27506 | IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) | 261.9 | |
| GSM27507 | IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) | 355.0 | |
| GSM27508 | IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) | 235.5 | |
| GSM27509 | ISCH_a (ischemia, 1st replicate) | 151.2 | |
| GSM27510 | ISCH_b (ischemia, 2nd replicate) | 404.1 | |
| GSM27511 | ISCH_c (ischemia, 3rd replicate) | 379.7 | |
| GSM27512 | ISCH_d (ischemia, 4th replicate) | 404.8 | |
| GSM27513 | ISCH_e (ischemia, 5th replicate) | 373.7 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 46.7 |
| GSM30791 | baseline control 02 | male, 275-300g | 100.9 |
| GSM30792 | baseline control 03 | male, 275-300g | 67.7 |
| GSM30793 | baseline control 04 | male, 275-300g | 15.6 |
| GSM30794 | baseline control 05 | male, 275-300g | 44.6 |
| GSM30795 | baseline control 06 | male, 275-300g | 37.3 |
| GSM30796 | baseline control 07 | male, 275-300g | 40.4 |
| GSM30797 | baseline control 08 | male, 275-300g | 50.5 |
| GSM30798 | baseline control 09 | male, 275-300g | 43.3 |
| GSM30799 | pain 01 | 77.8 | |
| GSM30800 | pain 02 | 70.6 | |
| GSM30801 | pain 03 | 63.4 | |
| GSM30802 | pain 04 | 91.6 | |
| GSM30803 | pain 05 | 38.7 | |
| GSM30804 | FC 01 | 80.4 | |
| GSM30805 | FC 02 | 28.8 | |
| GSM30806 | FC 03 | 75.9 | |
| GSM30807 | FC 04 | 52.1 | |
| GSM30808 | FC 05 | 90.4 | |
| GSM30809 | IFC 01 | 62.2 | |
| GSM30810 | IFC 02 | 71.4 | |
| GSM30811 | IFC 03 | 73.3 | |
| GSM30812 | IFC 04 | 38.6 | |
| GSM30813 | IFC 05 | 20.3 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 58.3 |
| GSM99801 | isoflurane 02 | male, 275-300g | 52.4 |
| GSM99802 | isoflurane 03 | male, 275-300g | 9.6 |
| GSM99803 | isoflurane 04 | male, 275-300g | 69.4 |
| GSM99804 | isoflurane 05 | male, 275-300g | 49.0 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 6.5639 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 6.7413 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 7.9786 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 6.3817 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 6.6538 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 7.1899 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 6.1435 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 7.5099 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 5.841 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 3.90917 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 3.37349 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 3.35972 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 3.77701 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 3.33459 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 3.55809 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 3.53364 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 3.73749 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 3.38689 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 3.49684 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 3.44133 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 3.3611 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 3.3047 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 3.44214 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 3.34208 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 3.25708 |
| ID | GSE205202 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat] |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208507 | Rat_Baseline_0h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.053551 |
| GSM6208508 | Rat_Baseline_0h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.296852 |
| GSM6208509 | Rat_Baseline_0h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.242609 |
| GSM6208510 | Rat_Baseline_0h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.307632 |
| GSM6208511 | Rat_Baseline_0h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.226392 |
| GSM6208512 | Rat_Vehicle_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.313546 |
| GSM6208513 | Rat_Vehicle_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.324245 |
| GSM6208514 | Rat_Vehicle_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.392942 |
| GSM6208515 | Rat_Vehicle_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.29081 |
| GSM6208516 | Rat_Vehicle_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.343856 |
| GSM6208517 | Rat_Vehicle_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.392151 |
| GSM6208518 | Rat_Vehicle_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.155164 |
| GSM6208519 | Rat_Vehicle_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.235167 |
| GSM6208520 | Rat_Vehicle_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.153765 |
| GSM6208521 | Rat_Vehicle_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.272551 |
| GSM6208522 | Rat_Vehicle_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.144917 |
| GSM6208523 | Rat_Vehicle_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.314026 |
| GSM6208524 | Rat_Vehicle_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.209704 |
| GSM6208525 | Rat_Vehicle_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.21962 |
| GSM6208526 | Rat_Vehicle_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.364606 |
| GSM6208527 | Rat_Vehicle_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.86356 |
| GSM6208528 | Rat_Vehicle_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.299719 |
| GSM6208529 | Rat_Vehicle_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.497784 |
| GSM6208530 | Rat_Vehicle_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.214875 |
| GSM6208531 | Rat_Vehicle_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.163982 |
| GSM6208532 | Rat_APAP_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.04039 |
| GSM6208533 | Rat_APAP_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.132241 |
| GSM6208534 | Rat_APAP_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.321788 |
| GSM6208535 | Rat_APAP_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.250507 |
| GSM6208536 | Rat_APAP_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.222962 |
| GSM6208537 | Rat_APAP_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.830351 |
| GSM6208538 | Rat_APAP_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 5.238185 |
| GSM6208539 | Rat_APAP_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.797518 |
| GSM6208540 | Rat_APAP_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 5.27168 |
| GSM6208541 | Rat_APAP_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.935911 |
| GSM6208542 | Rat_APAP_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.95605 |
| GSM6208543 | Rat_APAP_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.121626 |
| GSM6208544 | Rat_APAP_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.282799 |
| GSM6208545 | Rat_APAP_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.407819 |
| GSM6208546 | Rat_APAP_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.017549 |
| GSM6208547 | Rat_APAP_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.130455 |
| GSM6208548 | Rat_APAP_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.083933 |
| GSM6208549 | Rat_APAP_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.702075 |
| GSM6208550 | Rat_APAP_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.241492 |
| GSM6208551 | Rat_APAP_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.185669 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 3.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 0.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 1.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 1.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 1.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 2.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 2.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 1.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 4.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 4.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 0.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 0.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 0.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 0.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 1.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 0.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 3.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 0.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 1.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 5.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 0.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 1.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 4.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 0.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 3.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 3.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 0.245387 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 0.046937 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 0.093504 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 0.138185 |
| ID | GSE359 |
| Title | Isoflurane Single Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5120 | Isoflurane single exposure control-1 | 134.5 | |
| GSM5121 | Isoflurane single exposure control-2 | 87.8 | |
| GSM5122 | Isoflurane single exposure control-3 | 176.3 | |
| GSM5124 | Isoflurane single exposure 1 hr-1 | 215.6 | |
| GSM5126 | Isoflurane single exposure 1 hr-2 | 136.3 | |
| GSM5127 | Isoflurane single exposure 2 hr-1 | 112.9 | |
| GSM5130 | Isoflurane single exposure 2 hr-2 | 151.9 | |
| GSM5131 | Isoflurane single exposure 2 hr-3 | 131.8 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 4.454528727 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 4.281093917 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 4.415898939 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 4.443488146 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 4.404212046 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 4.326053607 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 5.091488105 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 4.500656086 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 4.761161393 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 4.683316114 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 5.516806587 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.704581716 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.251121225 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.592216639 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 4.531173652 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 4.845258412 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 5.930305184 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 4.871044848 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 4.669755041 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 4.758828685 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.847619746 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.44032833 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 4.805788424 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 4.794307694 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.641435 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.683919 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.669623 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.522693 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.639295 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.661488 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.681796 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.708299 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.626074 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.532244 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.617965 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.635875 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.646047 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.784566 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.679418 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.677523 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.717689 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.620622 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.592485 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.65299 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.627987 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.611215 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.695961 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.829905 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 114.3624 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 128.3469 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 81.09772305 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 78.85322384 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 121.0369233 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 62.37383204 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 10.51192916 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 85.21739933 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 97.88389017 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 86.10679267 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 30.49719157 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 40.57329428 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 29.66155529 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 69.13342907 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 54.02507435 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 43.22016436 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 4.454528727 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 4.281093917 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 4.415898939 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 4.443488146 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 4.404212046 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 4.326053607 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 5.091488105 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 4.500656086 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 4.761161393 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 4.683316114 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 5.516806587 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.704581716 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.251121225 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.592216639 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 4.531173652 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 4.845258412 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 5.930305184 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 4.871044848 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 4.669755041 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 4.758828685 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.847619746 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.44032833 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 4.805788424 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 4.794307694 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 81.09772305 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 78.85322384 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 121.0369233 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 62.37383204 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 10.51192916 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 85.21739933 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 97.88389017 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 86.10679267 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 30.49719157 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 40.57329428 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 29.66155529 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 69.13342907 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 54.02507435 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 43.22016436 |
| ID | GSE752 |
| Title | Halothane/Isoflurane Repetitive Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5082 | Control 1 | 158.1 | |
| GSM5084 | Control 2 | 236.7 | |
| GSM5085 | Control 3 | 164.1 | |
| GSM5086 | Control 4 | 187.6 | |
| GSM5087 | Control 5 | 197.2 | |
| GSM5090 | Control 6 | 154.8 | |
| GSM5105 | Control 7 | 162.3 | |
| GSM5106 | Control 8 | 183.7 | |
| GSM5107 | Control 9 | 207.6 | |
| GSM5108 | Halothane 10 exposure-1 | 159.6 | |
| GSM5109 | Halothane 10 exposures-2 | 151.4 | |
| GSM5110 | Halothane 10 exposures-3 | 173.6 | |
| GSM5111 | Halothane 5 exposures-1 | 148.8 | |
| GSM5112 | Halothane 5 exposures-2 | 190.3 | |
| GSM5113 | Halothane 5 exposures-3 | 194.3 | |
| GSM5114 | Isoflurane 10 exposures-1 | 134.0 | |
| GSM5115 | Isoflurane 10 exposures-2 | 174.7 | |
| GSM5116 | Isoflurane 10 exposures-3 | 133.1 | |
| GSM5117 | Isoflurane 5 exposures-1 | 159.9 | |
| GSM5118 | Isoflurane 5 exposures-2 | 158.8 | |
| GSM5119 | Isoflurane 5 exposures-3 | 147.8 | |
| GSM11379 | Control 10 | 177.1 | |
| GSM11380 | Control 11 | 198.3 | |
| GSM11381 | Control 12 | 204.2 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 11.4239 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 2.36058 |
